Literature DB >> 2745981

Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor.

G Chaudhri1, I A Clark.   

Abstract

Secretion of TNF from mouse peritoneal macrophages exposed to LPS in vitro was enhanced in the presence of H2O2 or sodium periodate. Neither of these agents induced release of TNF in the absence of LPS. Both iron chelators and free radical scavengers inhibited this enhanced secretion of TNF, implying the involvement of free radicals via a Fenton-type reaction. Oxidant stress, in the form of alloxan or divicine, also enhanced serum levels of TNF in mice made sensitive to LPS by low-level infection with malaria, and then given i.v. LPS. Pretreatment with the iron chelator, desferal, or the free radical scavenger, BHA, inhibited TNF release in these animals. Less TNF was also detected in mice given desferal before LPS in the absence of exogenous radical generator. These results could have implications for understanding the details of the MLR, the adherence of neutrophils to the walls of pulmonary vessels in free radical-induced lung pathology, and the side effects of bleomycin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2745981

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Using cytokines.

Authors:  R Grimble
Journal:  BMJ       Date:  1992-09-12

2.  Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine.

Authors:  M Sagara; J Satoh; R Wada; S Yagihashi; K Takahashi; M Fukuzawa; G Muto; Y Muto; T Toyota
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

3.  Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients.

Authors:  Roberto Fogari; Paola Preti; Annalisa Zoppi; Pierangelo Lazzari; Luca Corradi; Elena Fogari; Leonardina Ciccarelli; Giuseppe Derosa
Journal:  Eur J Clin Pharmacol       Date:  2006-08-02       Impact factor: 2.953

Review 4.  The oxidative stress theory of disease: levels of evidence and epistemological aspects.

Authors:  Pietro Ghezzi; Vincent Jaquet; Fabrizio Marcucci; Harald H H W Schmidt
Journal:  Br J Pharmacol       Date:  2016-08-04       Impact factor: 8.739

5.  Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease.

Authors:  L Lih-Brody; S R Powell; K P Collier; G M Reddy; R Cerchia; E Kahn; G S Weissman; S Katz; R A Floyd; M J McKinley; S E Fisher; G E Mullin
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

6.  Endotoxin induced production of interleukin-6 is enhanced by vitamin E deficiency and reduced by black tea extract.

Authors:  A M Amarakoon; P S Tappia; R F Grimble
Journal:  Inflamm Res       Date:  1995-07       Impact factor: 4.575

7.  Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load.

Authors:  C Elbim; S Pillet; M H Prevost; A Preira; P M Girard; N Rogine; H Matusani; J Hakim; N Israel; M A Gougerot-Pocidalo
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Leptin stimulates the oxidative burst in control monocytes but attenuates the oxidative burst in monocytes from HIV-infected patients.

Authors:  C Sánchez-Pozo; J Rodriguez-Baño; A Domínguez-Castellano; M A Muniain; R Goberna; V Sánchez-Margalet
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

9.  Enhancement of lipopolysaccharide-induced tumor necrosis factor production in mice by carrageenan pretreatment.

Authors:  M Ogata; S Yoshida; M Kamochi; A Shigematsu; Y Mizuguchi
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

10.  Membrane expression and shedding of tumour necrosis factor receptors during activation of human blood monocytes: regulation by desferrioxamine.

Authors:  C Philippe; P Roux-Lombard; B Fouqueray; J Perez; J M Dayer; L Baud
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.